Furthermore, we conducted an analysis of clinical follow-up records from 105 HCC patients to explore the correlation between HDAC2 expression and clinicopathological features, including tumor sizes, cirrhosis, HBV infection, and microvascular invasion. This evidence concerns the gene HDAC2 and hepatocellular carcinoma.